About Evoq Remedies Limited
Data last updated: 22 December 2025
Evoq Remedies Limited is a public limited company based in Ahmedabad, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 24 February 2010, the company has been in operation for over 16 years.
Registered with ROC Ahmedabad under CIN L46209GJ2010PLC059692. Listed on BSE: 543500.
Capital: an authorised share capital of ₹42 Cr and a paid-up capital of ₹24.9 Cr. Formerly known as Evoq Remedies Private Limited and Salus Life Science and Research Private Limited. It is led by directors including Bhumishth Narendrabhai Patel and Harsh Kothari.
Last AGM: 17 September 2025. Financial statements filed for year ended 31 March 2025. Office: Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.17 Cr, a growth of 125% compared to the previous year.
The company is associated with 1 brand - Evoq Remedies.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website evoqremedies.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressA – 1106 Empire Business Hub Near Auda Water Tank Science City Road, Sola, Ahmedabad, Gujarat, India – 380060
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Evoq Remedies Limited
Evoq Remedies Limited has undergone 2 name changes throughout its history. The company was previously known as Evoq Remedies Private Limited, and Salus Life Science And Research Private Limited. The current legal name is Evoq Remedies Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Evoq Remedies Limited | Current |
| Evoq Remedies Private Limited | Previous |
| Salus Life Science And Research Private Limited | Previous |
CIN History of Evoq Remedies Limited
Evoq Remedies Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L46209GJ2010PLC059692, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L46209GJ2010PLC059692 | Current |
| U24230GJ2010PLC059692 | Previous |
| L24230GJ2010PLC059692 | Previous |
| U24230GJ2010PTC059692 | Previous |
Associated Brands with Evoq Remedies Limited
Evoq Remedies Limited operates one associated brand: EVOQ Remedies. These brands represent Evoq Remedies Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| CDMO focused on manufacturing pharmaceutical formulation and marketing services | evoqremedies.com |
Competitors & Alternatives of Evoq Remedies Limited
Brands and companies operating in the same space as Evoq Remedies Limited include Pharmaron, Pfizer, Lonza and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Pharmaron
|
Drug discovery and development services for small molecules are provided. | Beijing, China, China | 2003 |
Pfizer
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
Lonza
|
CDMO services for pharma, biotech, and specialty ingredients are provided. | Basel, Switzerland, Switzerland | 1897 |
Dotmatics
|
AI powered scientific data management and workflow automation solutions | - | 2005 |
Boehringer Ingelheim
|
Generic drugs and clinical research services are provided globally. | - | 1885 |
LabConnect
|
Laboratory testing, clinical trial research, and biopharma services are provided. | Johnson City, United States, United States | 2002 |
Beta Drugs
|
Developer of therapeutics for oncology and dermatology | Panchkula, India, India | 2005 |
Ainos
|
Novel point-of-care testing and low-dose interferon therapeutics are developed. | San Diego, United States, United States | 1986 |
Biomatter
|
Provider of synthetic biology and AI-based technology for generative protein design | Vilnius, Lithuania, Lithuania | 2018 |
Auditor Details of Evoq Remedies Limited
Evoq Remedies Limited is audited by H Thakkar & Co. LLP (ICAI peer reviewed, certificate valid till 2027-05-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| H Thakkar & Co. LLP (ICAI peer reviewed, certificate valid till 2027-05-31) | FY 2026 | Statement on impact of audit qualification |
Board of Directors of Evoq Remedies Limited
Evoq Remedies Limited is currently managed by 4 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Bhumishth Narendrabhai Patel
Also directs:
Evoq Remedies Limited, Patron Exim Limited, Aquilae Worldwide Private Limited and 5 more
|
Managing Director | 01 Aug 2024 | 1 Years 11 Months | Current |
|
Harsh Kothari
Also directs:
Evoq Remedies Limited, Eforu Entertainment Limited
|
Director | 06 Sep 2024 | 1 Years 10 Months | Current |
|
Pushpa Joshi
Also directs:
Evoq Remedies Limited, Vintage Coffee And Beverages Limited, Take Solutions Limited and 2 more
|
Director | 31 Mar 2025 | 1 Years 3 Months | Current |
|
Narendrakumar Gangaramdas Patel
Also directs:
Evoq Remedies Limited, Patron Exim Limited, Aquilae Worldwide Private Limited and 5 more
|
Director | 11 Sep 2023 | 2 Years 10 Months | Current |
Financials of Evoq Remedies Limited FY 2026 filings available
Evoq Remedies Limited reported revenue of ₹25.51 Cr (up 116.96% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹25.51 Cr | ₹11.76 Cr | ₹4.05 Cr | ₹20.39 Cr | ₹16.78 Cr |
| Other Income | ₹1.25 Cr | ₹2.41 Cr | ₹2.26 Cr | ₹6.02 Cr | ₹0 |
| Total Income | ₹26.76 Cr | ₹14.17 Cr | - | - | - |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹20.58 Cr | ₹0 |
| Purchases of Stock-in-Trade | ₹24.93 Cr | ₹12.18 Cr | ₹2.65 Cr | ₹0 | ₹14.41 Cr |
| Changes in Inventories | ₹54.79 Lakh | ₹90.6 Lakh | -₹1.09 Cr | -₹1.25 Cr | -₹63.38 Lakh |
| Employee Benefit Expense | ₹6.89 Lakh | ₹6.82 Lakh | ₹7.75 Lakh | ₹20.39 Lakh | ₹17.3 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹13,000 | ₹46,000 |
| Other Expenses | ₹1.41 Cr | ₹84.45 Lakh | ₹4.06 Cr | ₹4.59 Cr | ₹1.37 Cr |
| Total Expenses | ₹27.01 Cr | ₹14.04 Cr | ₹5.7 Cr | ₹24.13 Cr | ₹15.32 Cr |
| Profit Before Tax | -₹25.1 Lakh | ₹12.82 Lakh | ₹61.14 Lakh | ₹2.28 Cr | ₹1.46 Cr |
| Total Tax Expense | -₹1.11 Lakh | ₹8.82 Lakh | ₹15.9 Lakh | ₹66.53 Lakh | ₹36.71 Lakh |
| Net Profit | -₹23.99 Lakh | ₹4 Lakh | ₹45.24 Lakh | ₹1.62 Cr | ₹1.09 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | ₹51.94 Cr | ₹50.01 Cr | ₹36.86 Cr | ₹34.9 Cr | ₹33.33 Cr |
| Non-current Assets | ₹17.2 Lakh | ₹22.31 Lakh | ₹1.4 Lakh | ₹93,000 | ₹0 |
| Current Assets | ₹51.77 Cr | ₹49.79 Cr | ₹36.85 Cr | ₹34.89 Cr | ₹33.33 Cr |
| Property, Plant & Equipment | ₹17.2 Lakh | ₹22.31 Lakh | - | - | - |
| Inventories | ₹1.67 Cr | ₹2.22 Cr | ₹3.13 Cr | ₹2.03 Cr | ₹78.44 Lakh |
| Cash & Equivalents | ₹52,000 | ₹21.41 Lakh | ₹12.34 Lakh | ₹15.36 Lakh | ₹3.09 Cr |
| Equity (Net Worth) | ₹44.3 Cr | ₹44.54 Cr | - | - | - |
| Current Liabilities | ₹7.64 Cr | ₹5.47 Cr | ₹11.62 Cr | ₹10.11 Cr | ₹10.17 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | -₹28.19 Lakh | -₹14.62 Cr | ₹5.32 Cr | -₹4.35 Cr | -₹26.43 Cr |
| Investing Cash Flow | ₹0 | -₹25.81 Lakh | -₹1.2 Lakh | -₹1.31 Lakh | ₹0 |
| Financing Cash Flow | ₹7.3 Lakh | ₹14.97 Cr | -₹5.34 Cr | ₹1.42 Cr | ₹29.49 Cr |
| Capital Expenditure | ₹0 | ₹25.81 Lakh | - | - | - |
| Free Cash Flow (computed) | -₹28.19 Lakh | -₹14.88 Cr | - | - | - |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹20.89 Lakh | ₹9.07 Lakh | -₹3.02 Lakh | -₹2.94 Cr | ₹3.06 Cr |
Charges & Borrowings Evoq Remedies Limited
Evoq Remedies Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Evoq Remedies Limited
View historical data on people associated with Evoq Remedies Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Evoq Remedies Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Evoq Remedies Limited
GSTIN & GST Filing Data of Evoq Remedies Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Evoq Remedies Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Evoq Remedies Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Evoq Remedies Limited
MSME Payment Delays by Evoq Remedies Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Evoq Remedies Limited
Subsidiaries & Group Companies of Evoq Remedies Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Evoq Remedies Limited with ownership details.
MCA Filings & Documents of Evoq Remedies Limited
MCA Filings & Documents of Evoq Remedies Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Evoq Remedies Limited
Frequently Asked Questions about Evoq Remedies Limited
Evoq Remedies Limited is an active public limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 24 February 2010 (16+ years old) and is registered under CIN L46209GJ2010PLC059692. Listed on BSE: 543500.
Evoq Remedies Limited reported revenue of ₹14.17 Cr for FY 2025 (up 125.00% YoY).
The current directors of Evoq Remedies Limited are:
The primary industry of Evoq Remedies Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes. Evoq Remedies Limited is listed on BSE with code 543500.
Evoq Remedies Limited can be reached at the registered office: A – 1106 Empire Business Hub Near Auda Water Tank Science City Road, Sola, Ahmedabad, Gujarat, India – 380060, or through the website evoqremedies.com.